Analyst Coverage

Firm Analyst Contact Information
Auriga USA, Inc.   Peter McDonald P: (212) 231-9057
B. Riley   Laura McGuigan, CFA P: (310) 689-2224
Citigroup   Lucy Lu, M.D. P: (212) 816-1441
Cowen & Co.   Doug Schenkel P: (617) 946-3918
GARP Research & Securities   Alastair Mackay, Ph.D. P: (410) 318-5022
Goldman Sachs & Co.   Isaac Ro P: (212) 902-6393
Jefferies & Company   Jon Wood P: (212) 336-7227
JMP Securities   Charles Duncan, Ph.D. P: (212) 906-3510
JP Morgan   Tycho Peterson P: (212) 622-6568
Ladenburg Thalmann & Co. Inc   Kevin DeGeeter P: (212) 409-2027
Leerink Swann   Dan Leonard P: (617) 918-4507
Macquarie Research   Dan Leone P: (212) 231-6369
Mizuho Securities USA Inc.   Peter Lawson P: (212) 205-8474
Morgan Joseph   Shiv Kapoor P: (917) 238-8207
Morningstar   Karen Anderson P: (312) 384-4826
Natixis Bleichroeder   Ashim Anand, Ph.D. P: (212) 698-3141
Oppenheimer & Co. Inc   David Ferreiro, Ph.D. P: (212) 667-8163
Piper Jaffray   William R. Quirk, CFA P: (612) 303-6858
RBC Capital Markets   Michael Yee P: (415) 633-8522
Stephens Inc.   Scott Gleason P: (501) 377-2362
William Blair & Company   Amanda Murphy P: (312) 364-8951

Myriad Genetics, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Myriad Genetics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Myriad Genetics, Inc. or its management. Myriad Genetics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.













Stock Information
Ticker:MYGN
Exchange: NASDAQ
Last Trade: $23.84
Change: up 0.18
Volume: 616,300

Feb 3, 2012  4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Contact
Rebecca Chambers
Director, Investor Relations
801-584-1143
rchamber@myriad.com